EDN1 and acute lymphoblastic leukemia: Finally, as regards the metabolic markers of endothelial dysfunction, namely HMW-AD, endothelin-1, and insulin resistance [64,65], in our study population we confirmed the reported data on impaired metabolic profile in young survivors of ALL [3]; however, we did not find any correlations with cardiovascular parameters and total doses of anthracyclines.